Department of Infectious Diseases, Cleveland Clinic, 9500 Euclid Avenue/G-21, Cleveland, OH 44195, USA.
Case Western Reserve University School of Medicine, 2109 Adelbert Road, Cleveland, OH 44106, USA.
J Antimicrob Chemother. 2018 Jul 1;73(7):1972-1977. doi: 10.1093/jac/dky133.
Patients receiving outpatient parenteral antimicrobial therapy (OPAT) may require emergency department (ED) visits to manage complications. This study's purpose was to identify risk factors for ED visits during OPAT and risk factors for hospitalization among patients with ED visits.
All OPAT courses initiated between 1 January 2013 and 1 January 2017 at Cleveland Clinic were identified. The first OPAT course per patient was included. For these, ED visits within 30 days were identified. Reasons and risk factors for these visits were sought, as were risk factors for hospitalization among patients visiting the ED.
Among 8263 patients on OPAT, 381 (4.6%) had at least one ED visit, an additional 1133 (14%) were hospitalized and an additional 50 (0.6%) died, within 30 days. One hundred and ninety-three ED visits (51%) were OPAT related. In a multivariable subdistribution proportional hazards competing risks regression model, prior ED visit (preceding year) was most strongly associated with ED visits (HR 2.29, 95% CI 1.76-2.98, P = 8.1 × 10-10). Eighty-five visits (22%) led to hospitalization. Compared with non-OPAT-related reasons, visits for vascular access complications were associated with lower odds of hospitalization (OR 0.36, 95% CI 0.14-0.83, P = 0.022) and visits for worsening infection with higher odds (OR 18.95, 95% CI 5.50-79.85, P = 1.2 × 10-7).
Compared with patients without, patients with prior ED visit have a 2.3-fold higher hazard of an ED visit within 30 days of OPAT initiation. Visits for worsening infection are much more likely to result in hospitalization than those for vascular access complications.
接受门诊静脉用抗菌药物治疗(OPAT)的患者可能需要到急诊部(ED)就诊以处理并发症。本研究的目的是确定 OPAT 期间 ED 就诊的危险因素,以及 ED 就诊患者住院的危险因素。
确定 2013 年 1 月 1 日至 2017 年 1 月 1 日期间克利夫兰诊所启动的所有 OPAT 疗程。每位患者的首次 OPAT 疗程均包括在内。对于这些患者,确定了 30 天内的 ED 就诊情况。寻找这些就诊的原因和危险因素,以及 ED 就诊患者住院的危险因素。
在 8263 名接受 OPAT 的患者中,381 名(4.6%)在 30 天内至少有一次 ED 就诊,另外 1133 名(14%)住院,另外 50 名(0.6%)死亡。193 次 ED 就诊(51%)与 OPAT 相关。在多变量亚分布比例风险竞争风险回归模型中,之前的 ED 就诊(前一年)与 ED 就诊最密切相关(HR 2.29,95%CI 1.76-2.98,P=8.1×10-10)。85 次就诊导致住院。与非 OPAT 相关的原因相比,血管通路并发症就诊与较低的住院可能性相关(OR 0.36,95%CI 0.14-0.83,P=0.022),而感染恶化就诊与较高的住院可能性相关(OR 18.95,95%CI 5.50-79.85,P=1.2×10-7)。
与无 ED 就诊史的患者相比,在开始 OPAT 后 30 天内,有 ED 就诊史的患者的 ED 就诊风险高 2.3 倍。感染恶化就诊比血管通路并发症就诊更有可能导致住院。